Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next-generation immune checkpoint targets, today announced the appointment of Frances Balkwill, Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, to its Scientific Advisory Board (SAB).
/PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that the Company...
Synthace, creators of the world's first digital life science experiment platform, today announced the appointment of Dr. Donald Deieso as the new Chairman of their Board. Dr. Deieso steps into this
DGAP-News: ABIVAX / Key word(s): Miscellaneous ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with...